About the Journal
Journal of Oncology Research & Clinical Treatment (JORCT) is a peer-reviewed, open-access international journal dedicated to publishing high-quality research, reviews, and case studies in the field of oncology. The journal aims to bridge the gap between laboratory research and clinical applications, offering a platform for clinicians, researchers, oncologists, and medical professionals to share findings that advance the understanding, diagnosis, and treatment of cancer.
JORCT promotes the dissemination of original discoveries in cancer biology, translational oncology, immunotherapy, surgical and radiation oncology, and novel therapeutic interventions. It provides timely updates on current trends and breakthroughs that impact clinical decision-making and patient outcomes in cancer care globally.
Aims and Scope
The Journal of Oncology Research & Clinical Treatment seeks to:
Encourage innovation and collaboration between basic scientists and clinical researchers in oncology.
Present cutting-edge research related to the prevention, diagnosis, treatment, and palliative care of cancer.
Foster global dissemination of studies addressing region-specific cancer burdens and treatment outcomes.
Provide a forum for critical discussions on personalized medicine, precision oncology, and clinical trial design.
The journal covers a wide range of topics, including but not limited to: Molecular and Cellular Oncology
Translational and Clinical Cancer Research
Chemotherapy and Radiotherapy Approaches
Immuno-oncology and Targeted Therapies
Surgical Oncology and Minimally Invasive Procedures
Biomarkers, Diagnostics, and Imaging
Hematologic Malignancies and Solid Tumors
Pediatric, Geriatric, and Rare Cancers
Cancer Epidemiology and Public Health
Quality of Life, Palliative Care, and Survivorship
π Keywords
Oncology
Cancer Research
Clinical Oncology
Chemotherapy
Radiotherapy
Immunotherapy
Targeted Therapy
Cancer Diagnosis
Tumor Biology
Cancer Treatment
Precision Oncology
Surgical Oncology
Translational Research
Biomarkers
Cancer Epidemiology
Palliative Care
Cancer Survivorship
Oncogenomic
Hematologic Malignancies
Solid Tumors
Alaa Kandil
Department of Clinical Oncology & Nuclear Medicine
Alexandria School of Medicine
Egypt
Andrew Hague
CellSonic Limited and the founder of Sapiens Shield
Honorary Fellow of the International Academy of Medical Sciences
United Kingdom
To reduce your wait time, complete the personal information on the form in advance. Although most routine tests are covered under your provincial health insurance plan, some tests may not be covered with knowledge is power.
we connect directly with patients to deliver their results so they have valuable health information when they need it most, we care about our people.
Find the nearest location for you online through our contact page, or just call us.
Contact UsYou can book an appointment online or contact us to send you one of our lab experts
Book a Home VisitSamples can be collected in our office, a lab, or the patient can collect the sample at home.
Order Test KitsResults are available for most tests within 7 days of samples reaching the lab.
View ResultsYour focus is on providing patients the best possible care and weβre here to help.
Accreditation & Licensing